DrWS: So right now, there are 140 clinical trials going on, on peptides
Diabetes in Remission (E11.A) A newer code, E11.A (Type 2 DM without complications, in remission), requires explicit provider documentation using the word remission. This code is appropriate for patients who have achieved sustained euglycemia through significant weight loss (bariatric surgery, intensive lifestyle intervention) and have discontinued all antidiabetic medications
This advance warning allows you to prioritize using peptides before they degrade or to plan experiments that will consume remaining stock
Open 10 , e4076 (2022)
Cognitive peptides in research: Semax, Selank, Dihexa and the new generation of peptide nootropics Cognition, the new frontier of research peptide therapy For decades, neuropeptide research focused on the major endocrine axes (hypothalamic-pituitary, opioids, oxytocin)